Press "Enter" to skip to content

New patent for Silvergate Pharms drug QBRELIS

0
Copyright © DrugPatentWatch. Originally published at New patent for Silvergate Pharms drug QBRELIS

Annual Drug Patent Expirations for QBRELIS
Annual Drug Patent Expirations for QBRELIS

Qbrelis is a drug marketed by Silvergate Pharms and is included in one NDA. It is available from one supplier. There are four patents protecting this drug.

Drug patent litigation for QBRELIS.

This drug has six patent family members in six countries.

The generic ingredient in QBRELIS is lisinopril. One supplier is listed for this compound. Additional details are available on the lisinopril profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Copyright © DrugPatentWatch. Originally published at New patent for Silvergate Pharms drug QBRELIS
    Do NOT follow this link or you will be banned from the site!